Scaleup Bio Accelerates Opportunities for Global Food Tech Start-Ups with 2023 Opening of Two Dedicated Food-Grade Precision Fermentation Facilities in Singapore

October 26, 2022 - 5 min read

  • First dedicated food-grade precision fermentation laboratories in Singapore and amongst few in the world truly catered towards start-ups and emerging food tech companies
  • Offering end-to-end Contract Development Manufacturing Organisation (CDMO) services from lab to market, including business and technical advisory, industry partnerships and investor access
  • Backed by ADM and Temasek’s Nurasa, formerly Asia Sustainable Foods Platform

Singapore, 26 October 2022 - ScaleUp Bio, a new, Singapore-homegrown precision fermentation solutions provider – a joint venture company of ADM and Temasek’s Nurasa – is positioning itself to emerge as a key enabler towards unlocking innovation for global food tech start-ups needing dedicated food-grade precision fermentation laboratory facilities and more.

ScaleUp Bio will open two dedicated food-grade precision fermentation facilities in Singapore during 2023. These new facilities will be the first of their kind in Singapore open to promising start-ups from anywhere in the world needing research and development assistance.

“Addressing urgent food security and supply issues driven by climate change and exacerbated by traditional food production sources – and in line with emerging consumer demands for more sustainably developed alternative proteins and other foods – has been a real challenge due to a lack of dedicated food-grade laboratory facilities, business guidance and market assistance for start-ups,” said Francisco Codoñer, ScaleUp Bio CEO.

“This has been because most CDMOs around the world cater first and foremost to pharmaceutical or biofuel industry needs. Which means start-ups and other early-stage firms often must resort to expensive and unpredictable laboratory capacities, often in an environment that was not meant for food. Building their own pilot facilities on the other hand would set up a high capital threshold out of the gate. We have designed ScaleUp Bio’s entire business model specifically to empower these young companies with the facilities, capabilities, and resources they have long needed to scale and succeed in today’s marketplace.”

Two world-class, dedicated food-grade precision fermentation facilities opening in 2023

ScaleUp Bio’s first facility opening in the first half of 2023 will be a joint laboratory developed under a new, multi-year partnership with the Singapore Agency for Science, Technology and Research (A*STAR)’s Singapore Institute of Food and Biotechnology Innovation (SIFBI), enabling delivery of tailored start-up infrastructure and service offerings. This facility, designed especially for research and development for start-ups and emerging food tech companies, will be able to support up to 100 litres of fermentation and downstream processing capacity, with analysis, testing and process optimisation capabilities. It will be located at Nurasa’s Food Tech Innovation Centre (FTIC) at Biopolis, a research and development hub in central Singapore.

The second facility – also scheduled for commercial launch during the second half of 2023 – will offer close to 2,300 square metres of space where start-ups and early-stage food tech companies from around the world can access up to 10,000 litres of fermentation and associated downstream processing capacity, with experts on-hand to continue the process optimisation and scale-up journey. This facility will also serve as ScaleUp Bio’s headquarters and will be located at LOGOS Food21, in Tuas, an emerging food manufacturing zone in the western part of Singapore.

Beyond physical laboratory facilities and technical expertise, ScaleUp Bio also offers food tech startups a comprehensive array of opportunities from its extensive business ecosystem.

Offering access to Asia and an innovation ecosystem supported by global leaders

“We understand the challenges faced by young firms seeking to navigate the complex regulations, cultures, and tastes across Asia. Thus, it makes perfect sense for us to launch our global offering from Singapore. From here, we can offer smart market entry to fast-growing Asian populations hungry for alternative sustainable food sources from one of the world’s great innovation centres,” Codoñer emphasised.

Through a holistic ecosystem of industry experts, partner organisations and resources from across ScaleUp Bio’s parent companies, precision fermentation start-ups will have access to an unprecedented array of resources and potential relationships to ensure commercial success. ADM is a global leader in nutrition and agricultural origination and processing and Nurasa is a new company focused on accelerating the commercialisation and adoption of sustainable food across Asia and is in turn wholly owned by Temasek, a global investment management company in Singapore.

“Whether you are a home-grown innovator here in Singapore or from across Asia – or a food tech company from anywhere in the world – we want to hear from you. With our new facilities, access to top-tier talent, resources, and capital, we offer a tremendous platform for young companies seeking to springboard their products to global scale and success,” concluded Codoñer.

Invitation to attend ScaleUp Bio’s In-person breakout session on 28 October 2022 at the 5th AsiaPacific Agri-Food Innovation Summit in Singapore

Interested parties are warmly invited to attend a special breakout session of the 5th Asia Pacific AgriFood Innovation Summit on Friday, 28 October 2022 at 2.50 pm, in Singapore, when ScaleUp Bio’s CEO Francisco Codoñer will share in an engaging session:

  • What are the biggest obstacles faced by new precision fermentation start-ups today, and what are the necessary steps they need to take to overcome them?
  • How can we better enable innovation and commercialisation today, to pave the way for better food and ingredients tomorrow?
  • What role can industry partners play in supporting this manufacturing revolution, and where do opportunities lie?

For more information about ScaleUp Bio’s breakout session and to register for the conference (paid registration required unless for media), please access

About ScaleUp Bio:

ScaleUp Bio is a Singapore-based, pioneering company providing dedicated food-grade precision fermentation facilities and comprehensive contract development and manufacturing organisation services for innovative start-up food tech companies from around the world.

ScaleUp Bio is a joint-venture company of ADM, global leader in nutrition and agricultural origination and processing and Nurasa, a new company focused on accelerating the commercialisation and adoption of sustainable food across Asia and wholly owned by Temasek, a global investment management company in Singapore.

Learn more about us today by visiting

Event Partners